438 related articles for article (PubMed ID: 29430695)
21. Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment.
Nadiminti H; Scope A; Marghoob AA; Busam K; Nehal KS
Dermatol Surg; 2010 Feb; 36(2):177-84. PubMed ID: 20039914
[No Abstract] [Full Text] [Related]
22. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
Ren M; Kong YY; Shen XX; Cai X; Kong JC
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
[No Abstract] [Full Text] [Related]
23. Topical imiquimod immunotherapy in the management of lentigo maligna.
Powell AM; Russell-Jones R; Barlow RJ
Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
[TBL] [Abstract][Full Text] [Related]
24. Locally Recurrent Lentigo Maligna and Lentigo Maligna Melanoma: Characteristics and Time to Recurrence After Surgery.
Connolly KL; Hibler BP; Lee EH; Rossi AM; Busam KJ; Nehal KS
Dermatol Surg; 2017 Jun; 43(6):792-797. PubMed ID: 28296789
[TBL] [Abstract][Full Text] [Related]
25. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment.
McKenna JK; Florell SR; Goldman GD; Bowen GM
Dermatol Surg; 2006 Apr; 32(4):493-504. PubMed ID: 16681656
[TBL] [Abstract][Full Text] [Related]
26. Surgical and histologic pitfalls in the management of lentigo maligna melanoma.
Situm M; Buljan M
G Ital Dermatol Venereol; 2012 Feb; 147(1):21-7. PubMed ID: 22370566
[TBL] [Abstract][Full Text] [Related]
27. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.
Guitera P; Collgros H; Madronio CM; Goumas C; Mann GJ; Watts CG; Pereira AR; Armstrong BK; Drummond M; Morton RL; Scolyer RA; Menzies SW; Thompson JF; Cust AE
Australas J Dermatol; 2019 May; 60(2):118-125. PubMed ID: 30302753
[TBL] [Abstract][Full Text] [Related]
28. Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna.
Robinson M; Primiero C; Guitera P; Hong A; Scolyer RA; Stretch JR; Strutton G; Thompson JF; Soyer HP
Dermatology; 2020; 236(2):111-116. PubMed ID: 31639788
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
[TBL] [Abstract][Full Text] [Related]
30. Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members.
Tio D; Prinsen CAC; Dréno B; Hoekzema R; Augustin M; van Montfrans C
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1476-1484. PubMed ID: 29419913
[TBL] [Abstract][Full Text] [Related]
31. Clinical findings are not helpful in detecting lentigo maligna melanoma in patients with biopsy-proven lentigo maligna.
Zoutendijk J; Koljenovic S; Wakkee M; Mooyaart AL; Nijsten T; van den Bos RR
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2325-2330. PubMed ID: 35730990
[TBL] [Abstract][Full Text] [Related]
32. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
Powell AM; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
[TBL] [Abstract][Full Text] [Related]
33. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.
Neumann I; Patalay R; Kaushik M; Timlin H; Daniel C
Eye (Lond); 2023 Feb; 37(3):408-414. PubMed ID: 35835989
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.
Cohen LM; McCall MW; Hodge SJ; Freedman JD; Callen JP; Zax RH
Cancer; 1994 Jun; 73(12):2964-70. PubMed ID: 8199993
[TBL] [Abstract][Full Text] [Related]
35. Lentigo maligna.
Samaniego E; Redondo P
Actas Dermosifiliogr; 2013 Nov; 104(9):757-75. PubMed ID: 22857817
[TBL] [Abstract][Full Text] [Related]
36. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy.
Guitera P; Moloney FJ; Menzies SW; Stretch JR; Quinn MJ; Hong A; Fogarty G; Scolyer RA
JAMA Dermatol; 2013 Jun; 149(6):692-8. PubMed ID: 23553208
[TBL] [Abstract][Full Text] [Related]
37. Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma.
Hedblad MA; Mallbris L
J Am Acad Dermatol; 2012 Jul; 67(1):60-8. PubMed ID: 22030019
[TBL] [Abstract][Full Text] [Related]
38. Treatment of lentigo maligna.
Gaspar ZS; Dawber RP
Australas J Dermatol; 1997 Feb; 38(1):1-6; quiz 7-8. PubMed ID: 9046644
[TBL] [Abstract][Full Text] [Related]
39. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up.
Bub JL; Berg D; Slee A; Odland PB
Arch Dermatol; 2004 May; 140(5):552-8. PubMed ID: 15148099
[TBL] [Abstract][Full Text] [Related]
40. Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions.
Moreno A; Manrique-Silva E; Virós A; Requena C; Sanmartín O; Traves V; Nagore E
JAMA Dermatol; 2019 Jul; 155(7):782-788. PubMed ID: 31066867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
